Facet Biotech (FACT) Shareholders Reject Biogen Idec (BIIB) Tender Offer

December 17, 2009 9:29 AM EST Send to a Friend
Facet Biotech Corporation (NASDAQ: FACT) commented on the filing by Biogen Idec Inc. (NASDAQ: BIIB) disclosing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login